Sign in
4/A

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000401

Options or other derivatives

  • Chief Financial Officer acquired 8,809 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-05 Exercise or conversion : show line 1 in the form Stock Options (Right to Buy) −8,809 0 D
Loading xslF345X03/edgar.xml…